# POSEIDA THERAPEUTICS INC (PSTX)

> Institutional ownership reported to the SEC as of Q1 2025, from Form 13F filings. Source: https://holderbook.com/stocks/PSTX/

- Reporting holders: 2
- Reported value: $308.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DekaBank Deutsche Girozentrale](https://holderbook.com/funds/1456228-dekabank-deutsche-girozentrale/) | $308.0K | 100,000 | 0.0% | 11 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $2 | 0 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2025 | 2 | $308.0K |
| Q4 2024 | 118 | $525.0M |
| Q3 2024 | 99 | $154.9M |
| Q2 2024 | 93 | $156.8M |
| Q1 2024 | 92 | $173.3M |
| Q4 2023 | 91 | $153.8M |
| Q3 2023 | 88 | $107.9M |
| Q2 2023 | 95 | $78.6M |
| Q1 2023 | 103 | $176.2M |
| Q4 2022 | 91 | $229.0M |
| Q3 2022 | 67 | $142.0M |
| Q2 2022 | 55 | $58.1M |